Given that a brand-name prescription drug stands to lose a significant chunk of its market share once a lower-price generic becomes available, you can understand why a drug company would want to do anything it can to delay the cheaper alternative, even if you disagree with their intentions. We’ve seen companies accused of paying millions to stave off competition through alleged “pay for delay” deals, and we’ve also seen examples of “product hopping” to prevent competitors from entering the field. Now here’s another method for keeping generics off the market: allegedly flooding the Food and Drug Administration with pointless paperwork. [More]
gumming up the works
Feds: Drug Company Delayed Cheaper Generics By Flooding The FDA With Paperwork
By 2.7.17 — Updated: 2.12.17
Graco Tells Parents With Recalled Car Seats They’re In For A 6-8 Week Wait
By 3.21.14
The good news, if you’re a safety-minded person, is that the recall on Graco car seats announced last month and expanded a few weeks later was very effective. Maybe it was more effective than Graco had anticipated, because there’s now a long wait for replacement buckles. [More]
